2017
DOI: 10.1002/bjs.10460
|View full text |Cite
|
Sign up to set email alerts
|

Assessment and validation of a novel angiographic scoring system for peripheral artery disease

Abstract: The ANGIO score provided a reproducible and valid assessment of the severity of lower-limb ischaemia and risk of major amputation and cardiovascular events in these patients with peripheral artery disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
25
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 23 publications
(26 citation statements)
references
References 34 publications
(42 reference statements)
1
25
0
Order By: Relevance
“…Estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease–Epidemiology Collaboration (CKD‐EPI) formula, as the authors had previously found this to be most accurately associated with complications in patients with PAD. A subset of included patients had the severity of PAD assessed by ankle : brachial pressure index (ABPI) and the ANGIO score measured by Doppler assessment and CT–angiography respectively, as described in detail previously.…”
Section: Methodsmentioning
confidence: 99%
See 4 more Smart Citations
“…Estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease–Epidemiology Collaboration (CKD‐EPI) formula, as the authors had previously found this to be most accurately associated with complications in patients with PAD. A subset of included patients had the severity of PAD assessed by ankle : brachial pressure index (ABPI) and the ANGIO score measured by Doppler assessment and CT–angiography respectively, as described in detail previously.…”
Section: Methodsmentioning
confidence: 99%
“…At recruitment, each patient's medications were recorded including whether they were prescribed a statin, aspirin, another antiplatelet agent, beta‐blocker, calcium channel blocker, angiotensin‐converting enzyme inhibitor, angiotensin receptor blocker, anticoagulants (warfarin or new anticoagulants), metformin, insulin, other diabetes medications or frusemide (for the treatment of cardiac failure).…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations